Blinded randomized crossover trial: Skin-to-skin care vs. sucrose for preterm neonatal pain
- PMID: 32152488
- DOI: 10.1038/s41372-020-0638-9
Blinded randomized crossover trial: Skin-to-skin care vs. sucrose for preterm neonatal pain
Abstract
Objective: To compare skin-to-skin care (SSC) and oral sucrose for preterm neonatal pain control.
Methods: Preterm neonates (28-36 weeks gestation) requiring heel-stick were eligible. In group-A, SSC was given 15-min before first heel-stick, and sucrose was given 2-min before second heel-stick. In group-B, the sequence was reversed. Blinded premature infant pain profile (PIPP) score assessment was done at 0, 1, and 5-min of heel-stick by two assessors.
Results: A hundred neonates were enrolled. The inter-rater agreement for the PIPP score was good. The behavior state component was significantly lower in the sucrose group at all assessment points. The mean (SD) difference between 1-min and 0 min was similar [SSC 3.58(3.16) vs. sucrose 4.09(3.82), p = 0.24] between groups. The PIPP score attained baseline values at 5-min in both groups.
Conclusion: Albeit sucrose indicated instantaneous action, SSC and sucrose have comparable clinical efficacy for preterm neonatal pain control. Multisensory stimulation with SSC may result in a higher behavioral state component of the PIPP score.
References
-
- Stevens B, Yamada J, Ohlsson A. Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev. 2010;1:CD001069.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical